<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="56649">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on April 10, 2017</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02368639</url>
  </required_header>
  <id_info>
    <org_study_id>CIA-156</org_study_id>
    <nct_id>NCT02368639</nct_id>
  </id_info>
  <brief_title>Feasibility of a Modified Positive Airway Pressure Device to Treat Sleep Disordered Breathing</brief_title>
  <official_title>Feasibility of a Modified Positive Airway Pressure Device to Treat Sleep Disordered Breathing</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Fisher and Paykel Healthcare</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Fisher and Paykel Healthcare</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study will use a modified version of a positive airway pressure device to supply air to
      the participant, while undergoing supervised polysomnography. Positive airway pressures are
      typically applied to many patients with hypoventilation, in this study these pressures will
      be titrated by a qualified sleep technician. During the night these pressures will be
      altered to optimise comfort.
    </textblock>
  </brief_summary>
  <overall_status>Active, not recruiting</overall_status>
  <start_date>February 2015</start_date>
  <completion_date type="Anticipated">December 2017</completion_date>
  <primary_completion_date type="Anticipated">December 2017</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>No masking</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Apnea hypopnea index (AHI)</measure>
    <time_frame>8 hours</time_frame>
    <description>The number of apnea and hypopneas will be measured</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Peripheral blood oxygen level (SpO2)</measure>
    <time_frame>8 hours</time_frame>
    <description>Peripheral blood oxygen level will be measured</description>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">100</enrollment>
  <condition>Sleep Apnea, Obstructive</condition>
  <condition>Obesity Hypoventilation Syndrome</condition>
  <arm_group>
    <arm_group_label>Positive airway pressure (PAP) device</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Participants will sleep overnight using a modified positive airway pressure device. Their pressures will be titrated by a qualified sleep technician, they will then be optimised during the night.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>F&amp;P modified CPAP</intervention_name>
    <description>The device is a modified version of the Fisher &amp; Paykel Icon continuous positive airway pressure (CPAP) device, which is a fully released product in New Zealand.</description>
    <arm_group_label>Positive airway pressure (PAP) device</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Aged 18+

          -  Patients diagnosed with obesity hypoventilation syndrome (OHS) and/or obstructive
             sleep apnea (OSA) by a practicing sleep or respiratory physician, requiring positive
             airway pressure (PAP) therapy

        Exclusion Criteria:

          -  Recent cardiac or respiratory arrest

          -  Gastro intestinal bleeding, ileus or recent gastrointestinal surgery

          -  Coma, decreased level of consciousness or agitation

          -  Anatomical or subjective difficulty with airway access e.g. facial surgery, trauma,
             vomiting upper airway obstruction

          -  Cerebrospinal fluid leak, abnormalities of the cribiform plate or prior history of
             head trauma.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Fisher &amp; Paykel Healthcare Sleep Laboratory</name>
      <address>
        <city>Auckland</city>
        <country>New Zealand</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>New Zealand</country>
  </location_countries>
  <verification_date>February 2017</verification_date>
  <lastchanged_date>February 13, 2017</lastchanged_date>
  <firstreceived_date>February 8, 2015</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Sleep Apnea, Obstructive</mesh_term>
    <mesh_term>Hypoventilation</mesh_term>
    <mesh_term>Obesity Hypoventilation Syndrome</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
